NexgenRx Inc.
NXG.V
TSX
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 11.31% | -7.71% | |||
| Total Other Revenue | 51.29% | -7.61% | |||
| Total Revenue | 12.69% | -7.71% | |||
| Cost of Revenue | 59.35% | -44.31% | |||
| Gross Profit | 4.84% | 3.76% | |||
| SG&A Expenses | 3.92% | -6.12% | |||
| Depreciation & Amortization | -3.01% | -0.66% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 12.34% | -15.19% | |||
| Operating Income | 15.22% | 170.33% | |||
| Income Before Tax | 8.56% | 249.19% | |||
| Income Tax Expenses | -104.63% | 2,144.05% | |||
| Earnings from Continuing Operations | 1,964.47% | -118.01% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 1,964.47% | -118.01% | |||
| EBIT | 15.22% | 170.33% | |||
| EBITDA | 56.91% | 5.60% | |||
| EPS Basic | 308.70% | -253.33% | |||
| Normalized Basic EPS | 6.90% | 262.50% | |||
| EPS Diluted | 275.00% | -260.00% | |||
| Normalized Diluted EPS | 0.00% | 262.50% | |||
| Average Basic Shares Outstanding | 0.92% | -0.87% | |||
| Average Diluted Shares Outstanding | 8.87% | -8.11% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | 1.02% | -17.74% | |||